Aggressive Phase Multiple Myeloma: A Terminal Anaplastic Transformation Resembling High-Grade Lymphoma

References

• Coleman M. Aggressive terminal phase of multiple myeloma. Arch Intern Med 1982; 142: 1755–1756
   PubMed Web of Science ®Google Scholar
• Suchman A L, Coleman M, Mouradian J A, et al. Aggressive plasma cell myeloma: A terminal phase. Arch Intern Med 1981; 141: 1315–1320
   PubMed Web of Science ®Google Scholar
• Bergsagel D E, Pruzanski W. Treatment of plasma cell myeloma with cytotoxic agents. Arch Intern Med 1975; 135: 172–176
   PubMed Web of Science ®Google Scholar
• Davis B W, Cousar J B, Collins R D. Oysplastic myeloma: An aggressive variant of multiple myeloma. Lab Invest 1981; 44: 14A
   Web of Science ®Google Scholar
• Falini B, DeSolas I, Levine A M, et al. Emergence of B-immunoblastic sarcoma in patients with multiple myeloma; A clinicopathologic study of 10 cases. Blood 1982; 59: 923–933
   PubMed Web of Science ®Google Scholar
• Blade J, Rozman C, Gianena A, Montserrat E. Aggressive terminal phase of multiple myeloma. Arch Intern Med 1982; 142: 1755
   PubMed Web of Science ®Google Scholar
• Garewal H, Durie B GM. Aggressive phase of multiple myeloma with pulmonary plasma cell infiltrates. JAMA 1982; 248: 1875–1876
   PubMed Web of Science ®Google Scholar
• Foucar K, Raber E, Foucar B, Barlogie B, Sandier C, Alexanian R. Anaplastic myeloma with massive extra-medullary involvement. Report of two cases. Cancer 1983; 51: 166–174
   PubMed Web of Science ®Google Scholar
• Strand W R, Banks P M, Kyle R A. Anaplastic plasma cell myeloma and immunoblastic lymphoma. Clinical, pathologic and immunologic comparison. Am J Med 1984; 76: 861–867
   PubMed Web of Science ®Google Scholar
• Durie B GM, Grogan T M. CALLA-positive myeloma: An aggressive subtype with poor survival. Blood 1985; 66: 229–232
   PubMed Web of Science ®Google Scholar
• Kaizer L, Bergsagel D E. Clinical pathological correlations of extramedullary plasma cell infiltrates in multiple myeloma. Proc Am Soc Clin Oncol 1986; 5: 157
   Google Scholar
• Gordon A J, Churg J. Multiple myeloma. Lesions of the extraosseous hematopoietic system. Am J Clin Pathol 1950; 20: 934–945
   PubMed Web of Science ®Google Scholar
• Hayes D W, Bennett W A, Heck F J. Extramedullary lesions in multiple myeloma-review of literature and pathologic studies. Arch Pathol 1952; 53: 262–272
   PubMedGoogle Scholar
• Pasmantier M W, Azar H A. Extraskeletal spread in multiple plasma cell myeloma. A review of 57 autopsied case. Cancer 1969; 23: 167–174
   PubMed Web of Science ®Google Scholar
• Innes J, Newell J. Myelomatosis. Lancet 1961; 1: 239–245
   PubMed Web of Science ®Google Scholar
• Wiltshaw E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine 1976; 55: 217–238
   PubMed Web of Science ®Google Scholar
• Kyle R A. Multiple myeloma. Review of 869 cases. Mayo Clin Proc 1975; 50: 29–40
   PubMed Web of Science ®Google Scholar
• Craft I L. The late appearance of extra-medullary lesions in myelomatosis. Br J Cancer 1967; 21: 501–504
   PubMed Web of Science ®Google Scholar
• Edwards G A, Zawadzki Z A. Extraosseous lesions in plasma cell myeloma. A report of six cases. Am J Med 1967; 43: 194–205
   PubMed Web of Science ®Google Scholar
• Holt A M, Robb-Smith A HT. Multiple myeloma Development of plasma cell sarcoma during apparently successful chemotherapy. J Clin Pathol 1973; 26: 649–659
   PubMed Web of Science ®Google Scholar
• Mundy G R, Baikie A G. Myeloma treated with cyclophosphamide and terminating in reticulum cell sarcoma. Med J Austral 1973; 1: 1240–1241
   PubMed Web of Science ®Google Scholar
• Osserman E F, Takatsuki K. Plasma cell myeloma: Gamma globulin synthesis and structure. Medicine 1963; 42: 357–384
   PubMed Web of Science ®Google Scholar
• Azar H A, Hill W T, Osserman E F. Malignant lymphoma and lymphatic kukemia associated with myeloma-type serum proteins. Am J Med 1957; 23: 239–249
   PubMed Web of Science ®Google Scholar
• Krauss S, Sokal J E. Paraproteinemia in the lymphomas. Am J Med 1966; 40: 400–413
   Web of Science ®Google Scholar
• Michaux J L, Heremans J F. Thirty cases of monoclonal immunoglobulin disorders other than myeloma or macroglobulinemia. A classification of diseases associated with the production of monoclonal-type immunoglobulins. Am J Med 1969; 46: 562–579
   PubMed Web of Science ®Google Scholar
• Maldonado J E, Kyle R A, Brown A L, Jr, Bayrd E D. Intermediate cell types and mixed cell proliferation in multiple myeloma: Electron microscopic observations. Blood 1960; 27: 212–226
   Google Scholar
• Okano H, Azar H A, Osserman E F. Plasmacytic reticulum cell sarcoma. Case report with electron microscopic studies. Am J Clin Pathol 1966; 46: 546–555
   PubMed Web of Science ®Google Scholar
• Taylor C R, Mason D Y. The immunohistochemical detection of intracellular immunoglobulin in formalin-paraffin sections from multiple myeloma and related conditions using the immunoperoxidase technique. Clin Exp Immunol 1974; 18: 417–429
   PubMed Web of Science ®Google Scholar
• Sun N CJ, Fishkin B G, Nies K M, et al. Lymphoplasmacytic myeloma. An immunological, immunohistochemical and electron microscopic study. Cancer 1979; 43: 2268–2278
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Pathologic Classification Project National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Taylor C R. Classification of lymphoma: ‘New thinking’ on old thoughts. Arch Pathol Lab Med 1978; 102: 549–554
   PubMed Web of Science ®Google Scholar
• Yen A, Fried J, Kitahara T, et al. The kinetic significance of cell size. II. Size distributions of resting and proliferating cells during interphase. Exp Cell Res 1975; 95: 303–310
   PubMed Web of Science ®Google Scholar
• Bayrd E D. The bone marrow on sternal aspiration in multiple myeloma. Blood 1948; 3: 987–1018
   PubMed Web of Science ®Google Scholar
• Bartl R, Frisch B, Burkhardt R, et al. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging. Br J Haematol 1982; 51: 361–375
   PubMed Web of Science ®Google Scholar
• Fritz E, Ludwig H, Kundi M. Prognostic relevance of cellular morphology in multiple myeloma. Blood 1984; 63: 1072–1079
   PubMed Web of Science ®Google Scholar
• Greipp P R, Raymond N M, Kyle R A, O'Fallon W M. Multiple myeloma: Significance of plasmablastic subtype in morphological classification. Blood 1985; 65: 305–310
   PubMed Web of Science ®Google Scholar
• Durie B GM, Salmon S E, Moon T E. Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma. Blood 1980; 55: 364–372
   PubMed Web of Science ®Google Scholar
• Drewinko B, Alexanian R, Boyer, et al. The growth fraction of human myeloma cells. Blood 1981; 57: 333–338
   PubMed Web of Science ®Google Scholar
• Durie B GM. Annotation: Is myeloma really a monoclonal disease?. Br J Haematol 1984; 57: 357–363
   PubMed Web of Science ®Google Scholar
• Durie B GM, Vela E, Baum V, et al. Establishment of two new myeloma cell lines from bilateral pleural effusions: Evidence for sequential in vivo clonal change. Blood 1985; 66: 548–555
   PubMed Web of Science ®Google Scholar
• Arnold A, Cossman J, Bakhshi A, et al. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med 1983; 309: 1593–1599
   PubMed Web of Science ®Google Scholar
• Penn I. Tumor incidence in human allograft recipients. Transplant Proc 1979; 11: 1047–1051
   PubMed Web of Science ®Google Scholar